Published in Int J Rad Appl Instrum B on January 01, 1990
Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine (2008) 0.91
Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet (1979) 7.28
Activation of production of infectious tumor virus SV40 in heterokaryon cultures. Proc Natl Acad Sci U S A (1967) 6.05
Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A (1978) 4.24
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J Biol Chem (1982) 3.97
Specific antigen in serum of patients with colon carcinoma. Science (1981) 3.68
Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc Natl Acad Sci U S A (1979) 3.46
Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res (1983) 3.15
Production of human hybridomas secreting antibodies to measles virus. Nature (1980) 2.32
Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours. Lancet (1982) 2.25
Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res (1982) 2.21
Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Cancer Res (1987) 2.14
A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science (1981) 2.02
Tube feedings in elderly patients. Indications, benefits, and complications. Arch Intern Med (1988) 1.94
Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells. Science (1983) 1.78
Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol (1982) 1.76
Are Alzheimer patients healthier? J Am Geriatr Soc (1988) 1.71
Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res (1980) 1.70
Peptide mimicry of carbohydrate epitopes on human immunodeficiency virus. Nat Biotechnol (1997) 1.61
Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol (1979) 1.59
Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci U S A (1990) 1.57
Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci U S A (1980) 1.54
Rescue of infectious SV40 after fusion between dfferent SV 40-transformed cells. Proc Natl Acad Sci U S A (1968) 1.43
Effects of monoclonal antibody immunotherapy on patients with gastrointestinal adenocarcinoma. J Biol Response Mod (1984) 1.41
Monoclonal antibodies directed against the human Leb blood group antigen. J Biol Chem (1981) 1.38
Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci U S A (1990) 1.35
The mechanism of internuclear transmission of SV40-induced complement fixation antigen in heterokaryocytes. Proc Natl Acad Sci U S A (1968) 1.35
Production of monoclonal antibodies in serum free medium. J Immunol Methods (1980) 1.33
Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol (1982) 1.31
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst (1985) 1.30
Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Cancer Res (1980) 1.27
Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci U S A (1984) 1.23
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst (1989) 1.23
Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type. Cancer Res (1988) 1.22
The interaction of murine IgG subclass proteins with human monocyte Fc receptors. J Immunol (1985) 1.21
Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study. Hybridoma (1983) 1.18
Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab Invest (1984) 1.18
Phase II clinical trial of a murine monoclonal antibody cytotoxic for gastrointestinal adenocarcinoma. Cancer Res (1985) 1.15
Neuro-psychiatric manifestations of typhoid. J Trop Med Hyg (1977) 1.15
Tumor growth modulation by a monoclonal antibody to the epidermal growth factor receptor: immunologically mediated and effector cell-independent effects. Cancer Res (1987) 1.13
Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 1.12
Reactivity of monoclonal anti-melanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol (1979) 1.10
Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody. Hybridoma (1983) 1.07
Monoclonal antibody-defined human lung cell surface protein antigens. Cancer Res (1982) 1.06
Mouse monoclonal antibodies against human cancer cell lines with specificities for blood group and related antigens. Characterization by antibody binding to glycosphingolipids in a chromatogram binding assay. J Biol Chem (1983) 1.06
Expression of DR antigens in freshly frozen human tumors. Hybridoma (1982) 1.05
Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Hybridoma (1982) 1.04
Alteration of cell surfaces with increased tumorigenicity. Arch Immunol Ther Exp (Warsz) (1977) 1.04
Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses. Nat Biotechnol (1999) 1.02
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants. Proc Natl Acad Sci U S A (1985) 1.02
Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation. J Immunol (1986) 1.01
Monoclonal antibodies directed against the sugar sequence of lacto-N-fucopentaose III are obtained from mice immunized with human tumors. Arch Biochem Biophys (1982) 1.00
Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial. Int J Radiat Oncol Biol Phys (1992) 1.00
Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res (1984) 0.99
Regional myocardial substrate uptake in hypertensive rats: a quantitative autoradiographic measurement. Science (1985) 0.99
Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy. Appl Radiat Isot (1998) 0.99
Isolation and chemical characterization of a melanoma-associated proteoglycan antigen. Arch Biochem Biophys (1983) 0.98
Radionuclide development at BNL for nuclear medicine therapy. Appl Radiat Isot (1998) 0.97
Production and characterization of monoclonal antibodies against human malignant melanoma. Cancer Invest (1983) 0.96
Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon. Cancer Res (1984) 0.95
CO 17-1A and related monoclonal antibodies: their production and characterization. Hybridoma (1986) 0.95
Pulmonary functions and their correlation with anthropomorphic parameters in young adults of Haryana (India). Indian J Physiol Pharmacol (1978) 0.94
Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. Cancer Res (1981) 0.93
Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. J Biol Chem (1985) 0.92
Ex vivo perfusion of a tumor-containing colon with monoclonal antibody. J Surg Res (1981) 0.92
Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy. J Biol Chem (1987) 0.91
Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells. Cell Immunol (1985) 0.91
Metastatic colon carcinoma detected with radiolabeled F(ab')2 monoclonal antibody fragments. Radiology (1983) 0.91
Prevention of falls in the elderly population. Arch Phys Med Rehabil (1988) 0.91
Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. Cancer Res (1987) 0.91
Uranium-loaded apoferritin with antibodies attached: molecular design for uranium neutron-capture therapy. Proc Natl Acad Sci U S A (1992) 0.90
A novel model of a metastatic human breast tumour xenograft line. Br J Cancer (1993) 0.90
Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci U S A (1995) 0.90
Ex vivo perfusion of human colon with monoclonal anticolorectal cancer antibodies. Cancer (1982) 0.90
Canine lymphoma-associated antigens defined by murine monoclonal antibodies. Cancer Immunol Immunother (1987) 0.89
Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines. Hybridoma (1999) 0.89
Lewis blood-type may affect the incidence of gastrointestinal cancer. Lancet (1982) 0.89
Colon carcinoma-associated glycoproteins recognized by monoclonal antibodies CO-029 and GA22-2. Hybridoma (1989) 0.88
Blood-group antigen expression during pancreatic cancer induction in hamsters. Int J Pancreatol (1986) 0.88
Structural characterization of the 'melanoma-specific' antigen detected by monoclonal antibody 691I5Nu-4-B. Mol Immunol (1981) 0.88
Hyperplastic polyps of the colon and rectum. An immunohistochemical study with monoclonal antibodies against blood groups antigens (sialosyl-Lea, Leb, Lex, Ley, A, B, H). Lab Invest (1987) 0.88
Comparison of antigen expression on normal urothelial cells in tissue section and tissue culture. J Urol (1990) 0.87
Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors. Am J Pathol (1982) 0.87
A new approach in specific, active immunotherapy. Cancer (1977) 0.86
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. Hybridoma (1985) 0.86
Coronary atherosclerosis and cardiovascular mortality in hemophilia. J Thromb Haemost (2009) 0.86
Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodies. Arch Biochem Biophys (1984) 0.85
Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies. Cell Immunol (1988) 0.85
Monoclonal antibody CO17-1A and leukapheresis in immunotherapy of pancreatic cancer. Hybridoma (1986) 0.85
Splenic sequestration of 99mTc labeled, heat treated red blood cells. Radiology (1980) 0.85
Correlative studies on antigenicity of pancreatic cancer and blood group types. Cancer Detect Prev Suppl (1987) 0.85
GD2 ganglioside biosynthesis is a distinct biochemical event in human melanoma tumor progression. FEBS Lett (1986) 0.85
Effects of carbaryl on the rat's male reproductive system. Vet Hum Toxicol (1995) 0.85
Effect of oral administration of carbofuran on male reproductive system of rat. Hum Exp Toxicol (1995) 0.84
Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies. Cancer Res (1990) 0.84
Indium-111-labeled LDL: a potential agent for imaging atherosclerotic disease and lipoprotein biodistribution. J Nucl Med (1990) 0.84
Production of antibodies in plants: approaches and perspectives. Curr Top Microbiol Immunol (2009) 0.84
Radionuclide-labeled red blood cells: current status and future prospects. Semin Nucl Med (1984) 0.84